Learn more about our Advocacy work.
According to a senior toxicologist in a RealClearPolicy op-ed, the EPA draws unreasonable conclusions about the health risks of the ethylene oxide used to sterilize medical technology.
AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on the recently issued proposed Transitional Coverage for Emerging Technologies (TCET) rule.
AdvaMed, The Medtech Association®, today called on the Biden Administration to implement a proposal to create a predictable pathway to national Medicare coverage for breakthrough medical technologies. The announcement comes…
It is easy to take for granted the role medtech plays in our everyday lives. From heart valves, imaging equipment, and pacemakers to continuous glucose monitors, we rely on these technologies to…
On March 29, AdvaMed® responded to the Senate HELP Committee’s request for information on policy priorities for the reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA).
Today, AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on the introduction of the bipartisan Verifying Accurate, Leading-edge IVCT Development (VALID) Act. Introduced in…
Today, AdvaMed, The Medtech Association®, applauded the introduction in the House and Senate of the bipartisan Saving Access to Laboratory Services Act (SALSA) by Senators Sherrod Brown (D-OH) and Thom…
Today, AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on the introduction of the bipartisan Ensuring Patient Access to Critical Breakthrough Products Act. The…
Each year in the U.S., ethylene oxide sterilizes 20 billion medical devices, which are critical to preventing serious, even life-threatening, infections.
AdvaMed®, the largest global trade organization representing medical technology companies, released the medtech industry’s “Medical Innovation Agenda for the 118th Congress.” These policy priorities would advance AdvaMed®’s goal to help…